Explore the latest developments concerning Blue Jays series.
Blue Jays series preview: New-look Royals head north of the border
Both the Royals and Blue Jays were active at the trade deadline
The Royals added four new players to the roster at the trade deadline – outfielder Mike Yastrzemski, and pitchers Ryan Bergert, Bailey Falter, and Stephen Kolek (who will likely head to the minors), in addition to the acquisitions of Randal Grichuk and Adam Frazier earlier in the month. The first-place Blue Jays made plenty of moves as well, picking up relievers Seranthony DomĂnguez and Louis Varland, as well as first baseman Ty France. The Jays just wrapped up their best month, going 18-8 in July and tying the Tigers for the best record in the American League.
Professional Drive Ratchet Wrench Household Multifunctional Repair Tool Ratchet For Air Refrigeration Tools MIAO-US
Royals Announce Series Of Roster Moves Ahead Of Friday's Opener With Blue Jays
The Kansas City Royals are still alive in the American League Wild Card race. While there are a few teams ahead of them for the final spot, they are only 3 1/2 games back, so a return trip to the postseason may not be a stretch.
They are 54-55 heading into a three-game weekend series with the Toronto Blue Jays. They were recently buyers at the trade deadline, adding Adam Frazier, Randal Grichuk, Mike Yastrzemski and Stephen Kolek.
On Friday, the team announced a series of roster moves ahead of the series opener with the Blue Jays.
Utilityman Nick Loftin was reinstated from the 7-Day Concussion Injured List. Yastrzemski was added to the active roster while both Kolek and outfielder MJ Melendez were optioned to Triple-A Omaha. Outfielder Joey Wiemer, who was acquired from the Cincinnati Reds in the Jonathan India trade, has been designated for assignment, while left-hander Kris Bubic has been transferred to the 60-Day Injured List.
For more detailed information and comprehensive insights, explore recent updates concerning Blue Jays series.
For more news, visit: For more newsâŚ



















0 Comments